Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Ovulation Testing Kits Market to Reach US$ 4.3 Bn by 2032 at 6.2% CAGR | Persistence Market Research
EIN Presswire
BRENFORD, LONDON, UNITED KINGDOM, July 13, 2026 /EINPresswire.com/ -- The global ovulation testing kits market is witnessing steady growth as consumers increasingly adopt home-based fertility monitoring solutions.
Seoul Pavilion Successfully Concludes at VivaTech 2026, Europe’s Largest Tech Stage
EIN Presswire
Substantial business matching outcomes lead to investment and collaboration with major European enterprises and local investors PARIS, FRANCE, July 13, 2026 /EINPresswire.com/ -- * “Seoul Night” was held successfully, attended by over 70 local...
Green Roof Market Expected to Reach US$ 10.8 Billion by 2033, According to Persistence Market Research
EIN Presswire
Growth is fueled by urbanization, climate regulations, and green building adoption.
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
GlobeNewswire, Inc.
Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318 in Alzheimer’s disease LAUSANNE, Switzerland, July 13, 2026 – Vandria, a clinical-stage biotech...
Real Estate Financial Modeling Reprices as Cap Rates Split by Asset Class in 2026
EIN Presswire
New 2026 data shows US commercial cap rates diverging by asset class as volume rebounds; eFinancialModels expands its real estate financial modeling templates.
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
GlobeNewswire, Inc.
Pratteln, Switzerland, July 13, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE® (vamorolone), extending the partnership to include Georgia, Kazakhstan,...
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer.
No easy answers: European research consortia take on major challenges
GlobeNewswire, Inc.
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological...
Brilliant Earth Launches The Solstice Collection, a Limited-Edition Swiss Watch Collection and its First Entry into the Category
GlobeNewswire, Inc.
SAN FRANCISCO, July 09, 2026 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. ("Brilliant Earth" or the "Company") (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced the launch of The Solstice...
Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges
GlobeNewswire, Inc.
A new peer-reviewed study validates CellEDIT’s ability to overcome cell-editing barriers, uncovering dermokine’s pivotal role in wound healing and skin cancer biology.
SEALSQ and GlobalFoundries Partner to Accelerate Post-Quantum Cryptography and Quantum Computing Technologies
GlobeNewswire, Inc.
Geneva, Switzerland, July 08, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (Nasdaq: LAES) ("SEALSQ") and GlobalFoundries (Nasdaq: GFS) (GF) today announced a strategic Memorandum of Understanding (MoU) to co-develop across secure semiconductor platforms,...
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
GlobeNewswire, Inc.
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials Dr. Ricordi to support advancement of NewcelX's Type 1 Diabetes program and...
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
GlobeNewswire, Inc.
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric...
WeRide Accelerates Global Expansion of Its End-to-End Intelligent Driving Solution
GlobeNewswire, Inc.
Key Highlights WeRide's one-stage end-to-end intelligent driving solution, built on its proprietary end-to-end driving algorithm and co-developed with Bosch, has begun on-road testing and localization validation in Germany, France, Japan and other...
Nepal 2035: A Policy Blueprint to Build the 'Switzerland of South Asia'
EIN Presswire
comprehensive study proposing institutional reform, economic transformation, and sustainable development to help Nepal become the “Switzerland of South Asia.” NEW YORK, NY, UNITED STATES, July 8, 2026 /EINPresswire.com/ -- 2510.org Releases...
Acronis Research and Development Wins Workforce Transformation Award at SGTech Industry Gala 2026
GlobeNewswire, Inc.
SINGAPORE, July 07, 2026 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, today announced that Acronis Asia Research and Development Pte Ltd has been named the SME category winner of the Workforce Transformation...
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 6, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. “In the first six months of 2026, we have made substantial...
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer
GlobeNewswire, Inc.
BASEL, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GlobeNewswire, Inc.
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® technology Focuses on patients at highest risk, including those with...
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.